Capital One National Association’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$279K Hold
11,461
– – 0.02% 425
2018
Q1
$196K Sell
11,461
-291
-2% -$5.68K 0.01% 497
2017
Q4
$223K Buy
11,752
+382
+3% +$5.75K 0.02% 485
2017
Q3
$200K Buy
11,370
+3,397
+43% +$76.4K 0.01% 510
2017
Q2
$265K Buy
+7,973
New +$247K 0.02% 449
2013
Q4
– Sell
-7,967
Closed -$301K – 578
2013
Q3
$301K Sell
7,967
-916
-10% -$35.7K 0.03% 417
2013
Q2
$348K Buy
+8,883
New +$346K 0.04% 353

Other funds holding TEVA

Capital One National Association's TEVA Position: Q2 2018 in Review

Capital One National Association held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2018 at 11,461 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #425.

Capital One National Association first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. The position peaked at $348K in Q2 2013. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • Capital One National Association held 11,461 shares of Teva Pharmaceutical Industries Limited worth $279K as of Q2 2018.
  • Capital One National Association left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2018.
  • Teva Pharmaceutical Industries Limited made up 0.02% of Capital One National Association's portfolio in Q2 2018, its #425 holding.
  • Capital One National Association first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 7 quarters since.
  • Capital One National Association's Teva Pharmaceutical Industries Limited position peaked at $348K in Q2 2013.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.